AreteMedical
Cambridge
About AreteMedical
AreteMedical is enabling early intervention and precision management of asthma, COPD, and other chronic lung disease. We do this with a patented platform, which for the first time unites the two key data types for these diseases: inflammation and airflow mechanics. This platform will let specialist-grade data be available in primary care, then at home for people with severe/unstable disease. Our vision is to be for asthma, the equivalent that CGM is for diabetes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $2.8M
- Last round: Non-Equity Assistance (Jun 2025)
- Website: aretemedtech.com
- Phone: [email protected]
Industries & Categories
Health Care, Health Diagnostics, Medical Device, Precision Medicine
Social Profiles
Canonical: https://fsome.com/organization/aretemedical-117905 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.